about
Aspirin: it's hard to beatEpileptogenic properties of cocaine in humansCocaine-induced seizuresCerebral atrophy in habitual cocaine abusers: a planimetric CT studyA cluster-randomized trial to improve stroke care in hospitalsBlood pressure management in acute ischemic strokePredictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial.Development of a decision aid for atrial fibrillation who are considering antithrombotic therapyEffects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trialFive-year rehospitalization outcomes in a cohort of patients with acute ischemic stroke: Medicare linkage study.Vertebrobasilar ectasia in patients with lacunar stroke: the secondary prevention of small subcortical strokes trial.A Comparison of Primed Low-frequency Repetitive Transcranial Magnetic Stimulation Treatments in Chronic Stroke.Trends in 10-year survival of patients with stroke hospitalized between 1980 and 2000: the Minnesota stroke surveyClinical epidemiology of atrial fibrillation and related cerebrovascular events in the United StatesStroke rates: 1980-2000: the Minnesota Stroke Survey.Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.ACP Journal Club: review: screening and treating asymptomatic adults with carotid artery stenosis lead to no net benefit.Senior medical students as simulated patients in an objective structured clinical examination: motivation and benefits.Incidence of progression or rebleeding in hypertensive intracerebral hemorrhage.Noninvasive carotid testing in threatened stroke. 2. Predictive performance.Serial treatments of primed low-frequency rTMS in stroke: characteristics of responders vs. nonresponders.Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis.Structured clinical teaching strategy.A pilot study of hyperbaric oxygen in the treatment of human stroke.Comparing students' feedback about clinical instruction with their performances.Better late than never?: the story of arterial recanalization in acute ischemic stroke.Atrial Fibrillation and Stroke: It's About Point of View.Ischemic stroke in patients with atrial fibrillation: effect of aspirin according to stroke mechanism. Stroke Prevention in Atrial Fibrillation Investigators.Atrial fibrillation and stroke in the general medicare population: a 10-year perspective (1992 to 2002).Morphological classification of penetrating artery pontine infarcts and association with risk factors and prognosis: The SPS3 trial.Primary and secondary stroke prevention in atrial fibrillation.Brain atrophy and chronic cocaine abuse: background and work in progress.Hospital-based versus community-based clinical education: comparing performances and course evaluations by students in their second-year pediatrics rotation.Thyrotoxic periodic paralysis with upper motor neuron findingsDefining "progressive stroke"Residents' perceptions of the effects of a practice plan on their trainingProgress report of the Stroke Prevention in Atrial Fibrillation Study
P50
Q28168197-B1B39115-BA29-4630-B448-829F20F468E6Q28324768-1E4B12E0-0A8E-4C98-B368-C0F891612AC5Q28329277-C2717DFD-F65B-4031-8C37-25DF8D7F77F2Q28334596-ACA6808F-ED29-48C2-91C4-77A1C852C86DQ33871670-A93BDF4D-6772-4F5E-92D9-6EF5DF0921EBQ34241649-8C223A30-F1B4-4C41-92D7-FCD786DBF80DQ34244196-92BE6345-F763-4A30-83C5-3063ECF41288Q34347755-BC3DEDAD-773D-4A1C-9AE7-FF6AD3418820Q34746642-CE3AA7EF-509C-47D5-9E83-48F9B2681DC6Q34837879-D05A67DD-A309-4E62-994D-FE53E64D6413Q35013765-6C6CABAE-1329-4504-881C-181AE7A415E7Q35533322-4CD2569F-5716-40C3-8626-F6D3FD040AA2Q36307505-5D606363-F69F-4656-9CF7-A99E3C8E4CAAQ36623581-566E2BE4-41DF-4B37-80EF-DA75FBC7BF4BQ37159030-6FD49529-7352-417F-9D19-C2DF8EDA5BBFQ37306121-3CCCAC4E-B31A-4AF7-9D46-DDEBAB1BC0A1Q37381165-1CC54915-FA5D-4103-B47B-71D53111FF18Q37567476-5EA9884D-5AB3-4A85-AA27-43598C53F72DQ37676164-F87A86AC-64CE-4F58-9FE7-FA0D2B4573F1Q38268741-9CDC7809-09D9-4B76-9647-FA11390430F9Q38555516-573D9184-F8D0-4DBF-BE0B-7706C0C6116FQ38612422-CCADDD17-2E71-4795-9FAC-7C3E1AC0E2F1Q39354920-69DAFCC7-9670-4F0E-AF31-C925AA32AEFCQ41440947-123F02C7-6CA2-49BC-AB0E-5E7E83EA074AQ44087244-F2879079-D898-45B2-B3C4-DF8B96781201Q44353112-A6CD37B8-0A03-4F2A-A845-E3D79BF9912BQ44615847-D5D13693-1567-4E38-BC98-A563315359D2Q45225947-2F31E397-4952-4783-B6C2-A58ED456362EQ48192096-2BF0A04C-067B-4388-B298-51A3BF794CFEQ48197017-15972EFE-09E9-4047-A73A-DFD1C9623B7CQ48362403-D9D7E9F3-7B4F-41DF-99A5-8A3E108FA843Q48482894-C3325051-7DDC-406D-9222-217171A67B2CQ48851859-EBFE9CC6-8A3A-410E-BD23-97E30DA5A48CQ50638000-9CC9CA3B-C388-45AD-93CB-48D053A97FCDQ51582541-34E56356-6671-4B18-981F-9A0FFEEDDBCEQ54048199-A17681EA-A3BD-466E-8D5A-CE5A33059854Q67405820-EF3E46D7-0B3E-40D2-9E97-FEA8E941E060Q67937335-52BA2EF2-38B8-4C29-8CC3-A0AAA2E4CB96Q68508995-D057DB92-6F87-4E03-B9F1-C037ABCC2A1CQ68599182-67982CD4-0F4C-404B-AF59-51C1788F59B8
P50
description
researcher ORCID ID = 0000-0001-9874-5649
@en
name
David C Anderson
@ast
David C Anderson
@en
David C Anderson
@es
David C Anderson
@nl
type
label
David C Anderson
@ast
David C Anderson
@en
David C Anderson
@es
David C Anderson
@nl
prefLabel
David C Anderson
@ast
David C Anderson
@en
David C Anderson
@es
David C Anderson
@nl
P1153
55483399300
P21
P31
P496
0000-0001-9874-5649